- Good news for Tropical Disease Research!
New collaboration between Pfizer and DNDi.
Pfizer Inc and Drugs for Neglected Diseases initiative (DNDi) have signed an agreement that is designed to facilitate advancements in the battle against human African trypanosomiasis (HAT), visceral leishmaniasis (VL) and Chagas disease, which afflict vulnerable populations in the developing world. Under the agreement, DNDi will have access [...]
- TDI presented at Duke-NUS (Singapore)
July 16th, 2009
TDI was presented at the DUKE-NUS University in Singapore. Slides can be found here.
- Blogging about TDI’s kernel start appearing…
Common Knowledge blog post
We are glad to see that our kernel is starting to spark some comments and posts in the blogsphere. For example, John Wilbanks, who runs the Science Commons project at Creative Commons, has some nice thoughts on our approach.
- More on our TDI kernel. Now in PLoS NTD!
PLoS Neglected Tropical Diseases published with full details our kernel.
The detailed description on how our The Tropical Disease Initiative kernel was produced have been published in the last issue of the PLoS Neglected Tropical Diseases journal. You can read about it in the PLoS NTD site at this link. For fair use, you can download the PDF here.
Marc A. [...]
- Our TDI kernel has been published!
Nature Biotech published our kernel.
The Tropical Disease Initiative kernel has been published in the last issue of the Nature Biotechnology journal as a correspondence to the Editor. You can read about it in the NatBioTech site at this link. The whole kernel will be published soon in the PLoS Neglected Tropical Diseases journal. We’ll keep [...]
- Open Source Drug Discovery. A feasible business model?
Open Source Drug Discovery. A feasible business model?
Jagadeesh Napa (Assistant Editor of Pharma Focus Asia) has a nice assay on Open Source Drug Discovery and is feasibility as a business model. We are glad that Jagadeesh has named TDI as one of the “major open source initiatives”.
- 2008 Target Competition for Neglected Diseases (UC Berkeley)
2008 Target Competition for Neglected Diseases (UC Berkeley)
As part of their upcoming symposium, Infection & Host Response (Dec. 12, 2008 at UC Berkeley, http://cend.berkeley.edu), the UC Berkeley Center for Emerging and Neglected Diseases is sponsoring a Target Competition in which the winner will receive a screen of up to 100,000 molecules in the QB3 Small Molecule Discovery Center (SMDC).
- TDI kernel. Second take.
We introduce our new TDI Kernel v1.0 to the public domain.
Open source drug discovery has so far remained elusive with few exceptions. We argue that the stumbling block has been the absence of a critical mass of preexisting work that volunteers can improve through a series of granular contributions. Historically, open source software collaborations have almost [...]
- New look for the tropicaldisease.org
Making our new web site public.
The Tropical Disease Initiative has a new web site look. We have move our content management to WordPress, which will help us to tell you better what is happening with our initiative.
Enjoy!
- Maurer on Open Source Drug Discovery
Open Source Drug Discovery: Finding A Niche
In retrospect, it was probably inevitable that admirers of open source software production would look for a second act. Before the 1990s, most commentators had imagined that the landscape of innovation consisted almost entirely of patents and copyright. This was never really true – careful policy makers have always considered other [...]
